Further evidence for the association of the NPSR1 gene A/T polymorphism (Asn107Ile) with impulsivity and hyperactivity

Journal of Psychopharmacology

Volumn 29, Issue 8, 2015, Pages 878-883

  Laas, Kariina ^a   Eensoo, Diva ^a   Paaver, Marika ^a   Lesch, Klaus Peter ^b,c,d   Reif, Andreas ^b,c,e   Harro, Jaanus ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Attention deficit hyperactivity disorder; Hyperactivity; Impulsivity; Neuropeptide S; Neuropeptide S receptor; NPSR1; Personality

Indexed keywords

ADAPTIVE AND MALADAPTIVE IMPULSIVITY SCALE; ADULT; ADULT ADHD SELF REPORT SCALE; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; BARRATT IMPULSIVENESS SCALE; CAR DRIVING; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; IMPULSIVENESS; MALE; NPSR1 GENE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RESTLESSNESS; SCORING SYSTEM; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; STUDENT; ADOLESCENT; COHORT ANALYSIS; ESTONIA; GENETICS; HYPERKINESIA; PHYSIOLOGY; SEX DIFFERENCE; YOUNG ADULT;

G PROTEIN COUPLED RECEPTOR; NPSR1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTOMOBILE DRIVING; COHORT STUDIES; ESTONIA; FEMALE; GENOTYPE; HUMANS; HYPERKINESIS; IMPULSIVE BEHAVIOR; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; SEX FACTORS; YOUNG ADULT;

EID: 84937883687     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115573803     Document Type: Article

References (34)

1. Banaschewski T, Becker K, Scherag S,. (2010) Molecular genetics of attention-deficit/hyperactivity disorder: An overview. Eur Child Adolesc Psychiatry 19: 237-257.
2. Beiderbeck DI, Lukas M, Neumann I, (2014) Anti-aggressive effects of neuropeptide S independent of anxiolysis in male rats. Front Behav Neurosci 8: 185.
3. Crosbie J, Arnold P, Paterson A,. (2013) Response inhibition and ADHD traits: Correlates and heritability in a community sample. J Abnorm Child Psychol 41: 497-507.
4. Dannlowski U, Kugel H, Franke F,. (2011) Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacology 36: 1879-1885.
5. Dickman SJ, (1990) Functional and dysfunctional impulsivity: Personality and cognitive correlates. J Pers Soc Psychol 58: 95-102.
6. Dickman SJ, (2000) Impulsivity, arousal and attention. Pers Indiv Diff 28: 563-581.
7. Domschke K, Reif A, Weber H,. (2011) Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Mol Psychiatry 16: 938-948.
8. Donner J, Haapakoski R, Ezer S,. (2010) Assessment of the neuropeptide S system in anxiety disorders. Biol Psychiatry 68: 474-483.
9. Eensoo D, Paaver M, Harro J, (2010) Factors associated with speeding penalties in novice drivers. Ann Adv Automot Med 54: 1-9.
10. Faraone SV, Perlis RH, Doyle AE,. (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 1313-1323.
11. Glotzbach-Schoon E, Andreatta M, Reif A,. (2013) Contextual fear conditioning in virtual reality is affected by 5HTTLPR and NPSR1 polymorphisms: Effects on fear-potentiated startle. Front Behav Neurosci 7: 31.
12. Kessler RC, Adler L, Ames M,. (2005) The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychol Med 35: 245-256.
13. Klauke B, Deckert J, Zwanzger P,. (2012) Neuropeptide S receptor gene (NPSR) and life events: G x E effects on anxiety sensitivity and its subdimensions. World J Biol Psychiatry 15: 17-25.
14. 107Ile variant and environment: Contribution to affective and anxiety disorders, and suicidal behaviour. Int J Neuropsychopharmacol 17: 541-552.
15. Laas K, Reif A, Herterich S,. (2010) The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity. Psychopharmacology 209: 255-261.
16. Laas K, Reif A, Akkermann K,. (2014b) Neuropeptide S receptor gene variant and environment: Contribution to alcohol use disorders and alcohol consumption. Addict Biol. Epub ahead of print 23 April 2014. DOI: 10.1111/adb.12149.
17. Laas K, Reif A, Kiive E,. (2014c) A functional NPSR1 gene variant and environment shape personality and impulsive action: A longitudinal study. J Psychopharmacol 28: 227-236.
18. Lesch KP, Timmesfeld N, Renner TJ,. (2008) Molecular genetics od adult ADHD: Converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 115: 1573-1585.
19. Lukas M, Neumann ID, (2012) Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: Social versus non-social effects. Neuropharmacology 62: 398-405.
20. Neumann ID, Veenema AH, Beiderbeck DI, (2010) Aggression and anxiety: Social context and neurobiological links. Front Behav Neurosci 4: 12.
21. Okamura N, Hashimoto K, Iyo M,.(2007) Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 31: 1444-1448.
22. Paaver M, Eensoo D, Kaasik K,. (2013) Preventing risky driving: A novel and efficient brief intervention focusing on acknowledgement of personal risk factors. Accident Anal Prev 50: 430-437.
23. Paaver M, Eensoo D, Pulver A,. (2006) Adaptive and maladaptive impulsivity, platelet monoamine oxidase (MAO) activity and risk-admitting in different types of risky drivers. Psychopharmacology 186: 32-40.
24. Paaver M, Nordquist N, Parik J,. (2007) Platelet MAO activity and the 5-HTT gene promoter polymorphism are associated with impulsivity and cognitive style in visual information processing. Psychopharmacology 194: 545-554.
25. Patton JH, Stanford MS, Barratt ES, (1995) Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51: 768-774.
26. Pulga A, Ruzza C, Rizzi A,. (2012) Anxiolytic- and panicolytic-like effects of neuropeptide S in the mouse elevated T-maze. Eur J Neurosci 36: 3531-3537.
27. Raczka KA, Gartmann N, Mechias M-L,. (2010) A neuropeptide S receptor variant associated with overinterpretation of fear reactions: A potential neurogenetic basis for catastrophizing. Mol Psychiatry 15: 1067-1074.
28. Reinscheid RK, (2008) Neuropeptide S: Anatomy, pharmacology, genetics and physiological functions. Results Probl Cell Differ 46: 145-158.
29. Reinscheid RK, Xu YL, Okamura N,. (2005) Pharmacological characterization of human and murine neuropeptide S receptor variants. J Pharmacol Exp Ther 315: 1338-1345.
30. Rizzi A, Vergura R, Marzola G,. (2008) Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice. Br J Pharmacol 154: 471-479.
31. Smith KL, Patterson M, Dhillo WS,. (2006) Neuropeptide S stimulates the hypothalamopituitary-adrenal axis and inhibits food intake. Endocrinology 147: 3510-3518.
32. Tupak SV, Reif A, Pauli P,. (2013) Neuropeptide S receptor gene: Fear-specific modulations of prefrontal activation. Neuroimage 66: 353-360.
33. Vaht M, Merenäkk L, Mäestu J,. (2014) Serotonin transporter gene promoter polymorphism (5-HTTLPR) and alcohol use in general population: Interaction effect with birth cohort. Psychopharmacology 231: 2587-2594.
34. Xu YL, Reinscheid RK, Huitron-Resendiz S,. (2004) Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43: 487-497.